» Articles » PMID: 20179802

Application of Machine Learning Methodology for PET-based Definition of Lung Cancer

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2010 Feb 25
PMID 20179802
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We applied a learning methodology framework to assist in the threshold-based segmentation of non-small-cell lung cancer (NSCLC) tumours in positron-emission tomography-computed tomography (PET-CT) imaging for use in radiotherapy planning. Gated and standard free-breathing studies of two patients were independently analysed (four studies in total). Each study had a pet-ct and a treatment-planning ct image. The reference gross tumour volume (GTV) was identified by two experienced radiation oncologists who also determined reference standardized uptake value (SUV) thresholds that most closely approximated the GTV contour on each slice. A set of uptake distribution-related attributes was calculated for each PET slice. A machine learning algorithm was trained on a subset of the PET slices to cope with slice-to-slice variation in the optimal suv threshold: that is, to predict the most appropriate suv threshold from the calculated attributes for each slice. The algorithm's performance was evaluated using the remainder of the pet slices. A high degree of geometric similarity was achieved between the areas outlined by the predicted and the reference SUV thresholds (Jaccard index exceeding 0.82). No significant difference was found between the gated and the free-breathing results in the same patient. In this preliminary work, we demonstrated the potential applicability of a machine learning methodology as an auxiliary tool for radiation treatment planning in NSCLC.

Citing Articles

A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.

Kotoulas S, Spyratos D, Porpodis K, Domvri K, Boutou A, Kaimakamis E Cancers (Basel). 2025; 17(5).

PMID: 40075729 PMC: 11898928. DOI: 10.3390/cancers17050882.


Ensemble learning driven Kolmogorov-Arnold Networks-based Lung Cancer classification.

Sait A, AlBalawi E, Nagaraj R PLoS One. 2024; 19(12):e0313386.

PMID: 39739892 PMC: 11687918. DOI: 10.1371/journal.pone.0313386.


Radiomics at a Glance: A Few Lessons Learned from Learning Approaches.

Capobianco E, Deng J Cancers (Basel). 2020; 12(9).

PMID: 32872466 PMC: 7563283. DOI: 10.3390/cancers12092453.


Adaptive region-growing with maximum curvature strategy for tumor segmentation in F-FDG PET.

Tan S, Li L, Choi W, Kang M, DSouza W, Lu W Phys Med Biol. 2017; 62(13):5383-5402.

PMID: 28604372 PMC: 5497763. DOI: 10.1088/1361-6560/aa6e20.


Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.

Hatt M, Lee J, Schmidtlein C, El Naqa I, Caldwell C, De Bernardi E Med Phys. 2017; 44(6):e1-e42.

PMID: 28120467 PMC: 5902038. DOI: 10.1002/mp.12124.


References
1.
Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C . Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2006; 34(4):453-62. DOI: 10.1007/s00259-006-0252-x. View

2.
Yu H, Liu Y, Hou M, Liu J, Li X, Yu J . Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer. Eur J Radiol. 2008; 72(1):104-13. DOI: 10.1016/j.ejrad.2008.06.015. View

3.
El Naqa I, Yang D, Apte A, Khullar D, Mutic S, Zheng J . Concurrent multimodality image segmentation by active contours for radiotherapy treatment planning. Med Phys. 2008; 34(12):4738-49. DOI: 10.1118/1.2799886. View

4.
Gregoire V, Haustermans K, Geets X, Roels S, Lonneux M . PET-based treatment planning in radiotherapy: a new standard?. J Nucl Med. 2007; 48 Suppl 1:68S-77S. View

5.
Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rube C . Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med. 2005; 46(8):1342-8. View